Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule
ArticleAbstract: We previously reported that CIMAvax-EGF vaccine is safe, immunogenic and efficacious to treat advancPalabras claves:antibodies affinity, cancer vaccine, EGF, NSCLC, surrogate biomarkerAutores:Alvarez K., Carmen Elena Viada, Fuentes K.P., García Verdecia B., González A., Gonzalez Z., Huerta V., Mazorra Z., Neninger Vinageras E., Popa X., Rodríguez P.C., Tania CrombetFuentes:scopusMolecular characterization of recombinant human interferon alpha-2b produced in Cuba
ArticleAbstract: The recombinant human interferon α 2b (IFN-γ(2b)) produced by Cuban technology is obtained from EschPalabras claves:IFN, Molecular characterization, Recombinant human interferon alfa 2bAutores:Beldarrain A., Besada-Pérez V., Betancourt L., Brito R., Curras T., Eugenio Hardy, Ferrero J., Gil M., González L.J., Herrera L., Huerta V., Martinez E., Moya G., Pujols V., Sanchez J.C., Santana-Milián H., Sosa R., Vivian Morera CórdovaFuentes:googlescopus